Cancer Research Cell Death Mechanisms and Cancer Therapy  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 46, 5482-5485, November 1, 1986]
© 1986 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Batist, G.
Right arrow Articles by Myers, C. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Batist, G.
Right arrow Articles by Myers, C. E.

Selenium-induced Cytotoxicity of Human Leukemia Cells: Interaction with Reduced Glutathione

Gerald Batist1, Aspandiar G. Katki, Raymond W. Klecker, Jr. and Charles E. Myers

Clinical Pharmacology Branch, National Cancer Institute, Bethesda, Maryland 20892

Selenium exists in a number of forms with differing valence states, some of which have shown antitumor activity. We studied the tumoricidal activity of four currently available selenium forms against a human leukemia cell line and exploited the differences among them to investigate the mechanism of antitumor action. Only selenocystine and sodium selenite showed antitumor activity, and these were also the only compounds which demonstrated significant redox chemistry, including depletion of cellular glutathione, stimulation of glutathione reductase, and stimulation of oxygen consumption. The interaction of these two compounds with glutathione suggests an intriguing potential role for them in cancer therapy.

1 To whom requests for reprints should be addressed, at Montreal General Hospital Research Institute, Room 960, U.S.C., 1650 Cedar Avenue, Montreal, Quebec H3G 1A4, Canada.

Received 1/ 8/86. Revised 7/ 8/86. Accepted 8/ 6/86.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. Tarze, M. Dauplais, I. Grigoras, M. Lazard, N.-T. Ha-Duong, F. Barbier, S. Blanquet, and P. Plateau
Extracellular Production of Hydrogen Selenide Accounts for Thiol-assisted Toxicity of Selenite against Saccharomyces cerevisiae
J. Biol. Chem., March 23, 2007; 282(12): 8759 - 8767.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
B. Lipinski
Re: Science Peels the Onion of Selenium Effects on Prostate Carcinogenesis
J Natl Cancer Inst, November 3, 2004; 96(21): 1640 - 1640.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1986 by the American Association for Cancer Research.